Media & Resources

NEW DELHI, March 3, 2011—The Translational Health Sciences and Technology Institute (THSTI), an autonomous institute of the Indian government’s Department of Biotechnology, and the International AIDS Vaccine Initiative (IAVI) announced today an agreement to jointly establish, operate and fund an HIV Vaccine Design Programme in India. The program will include the establishment of a new…

Phase I Clinical Trial to Test Combination of Two Experimental HIV Vaccine Components New York, February 28, 2011 – The International AIDS Vaccine Initiative (IAVI) today announces the start of a multi-center Phase I trial in Africa to evaluate the safety and immunogenicity of a preventive AIDS vaccine candidate made up of two components. The trial,…

New York, February 4, 2011 – IAVI is distressed and saddened by the tragic murder in Uganda last week of David Kato, an activist in the fight against AIDS and for the rights of sexual minorities in Africa. Three decades of experience with HIV/AIDS have clearly demonstrated that stigma is a barrier to effective responses to…

On this World AIDS Day we commemorate the lives lost to AIDS and honor all those who have worked so tirelessly over the decades to prevent the spread of HIV and help people affected by the disease. Those who have served that cause in communities and laboratories across the globe have plenty to celebrate on…

IAVI’s Board, management and staff extend their deepest sympathy and best wishes to those adversely affected by Hurricane Sandy. IAVI’s offices at 125 Broad Street in New York City, located near the East River, are temporarily closed owing to the damage to the building from the storm. We are in the process of relocating as…

MVI, International AIDS Vaccine Initiative, and Imperial College London  Establish Collaboration to Guide Selection and Prioritization of  Malaria Vaccine Candidates  WASHINGTON, DC (20 August 2012)—In response to a critical gap in developing malaria vaccines, the PATH Malaria Vaccine Initiative (MVI) announced a new collaboration today with the International AIDS Vaccine Initiative (IAVI) and Imperial College…

New Delhi, August 13, 2012—Former President of India, the Honourable Dr APJ Abdul Kalam inaugurated the International Symposium, “Accelerating India’s Response to Research for a Preventive HIV Vaccine”, devoted exclusively to HIV vaccine design and development, held today at the New Delhi Municipal Council (NDMC) Convention Centre. The two-day symposium has been organized by the…

NEW YORK, NY, July 31, 2012—The International AIDS Vaccine Initiative (IAVI) today announced the appointment to its Board of Directors of Alice P. Albright, Executive Vice President and Chief Operating Officer of the Export-Import Bank of the United States, and Dr. Purnima Mane, President and Chief Executive Officer of Pathfinder International. They join a diverse…